21.04.2015 • News

ExxonMobil President Says Bureaucracy Strangling LNG Exports

The US is at risk of losing economic opportunity and the ability to solidify its role as a global leader in energy production if policymakers do not quickly move to approve liquefied natural gas (LNG) exports, Rob Franklin, president of ExxonMobil Gas & Power Marketing Company, said in a speech at the Johns Hopkins School of Advanced International Studies in Washington DC.

With bureaucracy stalling legislation and issuance of export permits, the US role as world's leading energy producer is at stake, Franklin added. In his view, exports of LNG "should be treated no differently from other exports such as agricultural goods, automobiles and computer products.

"LNG exports can provide the spur to further increase America's natural gas production, providing all the attendant benefits that would generate," the executive said.

ExxonMobil is currently engaged in a $10 billion project to convert the LNG regasification terminal at Golden Pass, Texas, into an LNG export terminal. An application to export to non-Free Trade Agreement countries was submitted to federal officials more than two years ago, but no decision has been made.

Permit applications for some two dozen other projects are also in the same state of "bureaucratic limbo."

As global LNG demand is expected to triple between 2010 and 2040, the amount of incremental gas needed to meet global demand by 2025 will be almost double the size of the entire U.S. gas market today," Franklin said, adding that most of the new demand will come from existing and emerging markets in Asia-Pacific and the Middle East.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read